Search results

309 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC spin-off receives $3M Small Business Innovation Research grant
Chapel Hill, NC – G-Zero Therapeutics, an RTP company started in 2008 based on technologies from the University of North Carolina at Chapel Hill, has been awarded a $3 million Phase II Small Business Innovation Research Grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
Located in News / 2011 News
Peer Connect Program trains survivors to “guide” patients and fellow survivors
Peer Connect provides training for cancer survivors who wish to "give back" by talking with or being a buddy to another patient or survivor. Peer Connect meets a need for more formalized training for the "guides" or peer counselors by teaching effective communication skills and strategies based on Motivational Interviewing (MI), which focuses on listening and meeting the needs of the recipient rather than giving advice or telling people what to do.
Located in News / 2012 News
Protein associated with childhood cancer alters the structure of DNA, leading to cancer, UNC study shows
Chapel Hill - UNC scientists have demonstrated for the first time how a critical gene associated with a type of childhood cancer alters the way DNA is packaged in cells and leads to cancer. Their laboratory discovery could result in the development of a targeted therapy to treat Ewing Sarcoma, a malignant bone and soft tissue tumor of children and young adults.
Located in News / 2011 News
New resource for single fathers due to cancer
A new website for Single Fathers Due to Cancer has been launched as a way to help fathers more easily find resources and support.
Located in News / 2012 News
UNC surgeons co-author study on breast cancer treatment decision making
Chapel Hill, NC - How much medical information does a woman understand and retain about her breast cancer diagnosis? UNC scientists participated in a four-institution study involving 440 women with early-stage breast cancer and found that breast cancer survivors had limited knowledge about their surgical options, including an understanding of something as important as the risk of recurrence.
Located in News / 2012 News
Dr. Kimberly Kasow joins UNC School of Medicine Department of Pediatrics to lead pediatric bone marrow transplantation program
Chapel Hill, NC - Kimberly Kasow, DO, has joined the University of North Carolina at Chapel Hill as director of the UNC Pediatric Bone Marrow Transplantation program. Kasow is an associate professor of pediatrics and a member of the UNC Lineberger Comprehensive Cancer Center.
Located in News / 2011 News
Rapid rise of robotic surgery in treating cancer, Stitzenberg quoted
Karyn Stitzenberg, MD, MPH, is quoted in an article titled "Tracking the Rise of Robotic Surgery for Prostate Cancer" published in the August 9, 2011 issue of the NCI Cancer Bulletin.
Located in News / 2011 News
B Cell survival holds key to chronic graft vs. host disease
Chapel Hill, NC – Leukemia and lymphoma patients who receive life-saving stem cell or bone marrow transplants often experience chronic side effects that significantly decrease quality of life, can last a lifetime, and ultimately affect their long-term survival.
Located in News / 2012 News
Small DNA circles found outside the chromosomes in mammalian cells and tissues, including human cells
CHAPEL HILL, N.C. – Researchers from the University of North Carolina at Chapel Hill have helped identify a new DNA entity in mammalian cells and provided evidence that their generation leaves behind deletions in different locations of the cells’ genetic program, or genome.
Located in News / 2012 News
Genetically-engineered preclinical models predict pharmacodynamic response
Preclinical testing a necessary step in drug development
Located in News / 2012 News